Oncosil Medical Ltd has released a press release.
OncoSil Medical: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Two key treatment centres treat first patients with OncoSil
- OncoSil achieves milestone of 10 patients treated in Spain
- Distribution agreement signed for selected Chinese markets
- 2022 AGM CEO Presentation
- OncoSil Receives $832k R&D Tax Incentive
Later from OncoSil Medical
- Half-Yearly Report Results
- Entitlement Offer to raise up to $9.9 million
- Entitlement Offer Presentation
- Commitment received for Offer and updated Timetable
- Non-renounceable Rights Issue Offer Prospectus
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical